PFG
52
13
DUK
60
-2
KO
60
11
GE
67
2
BWA
50
5
OXY
48
2
JBHT
40
5
BBY
38
3
R
62
2
ABT
63
3
NEE
49
-5
AME
54
4
MNST
57
-2
BSX
70
3
FITB
62
3
NOV
49
4
HD
44
4
HST
37
5
PCAR
31
3
GD
49
-8
PFG
52
13
DUK
60
-2
KO
60
11
GE
67
2
BWA
50
5
OXY
48
2
JBHT
40
5
BBY
38
3
R
62
2
ABT
63
3
NEE
49
-5
AME
54
4
MNST
57
-2
BSX
70
3
FITB
62
3
NOV
49
4
HD
44
4
HST
37
5
PCAR
31
3
GD
49
-8
Financhill
Back

Verisk Analytics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
59

VRSK
Verisk Analytics

Last Price:
$286.06
Seasonality Move:
5.59%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$291.18
Seasonality Move:
3.3%
Buy
59
Verisk Analytics (VRSK) is a Buy

Is Verisk Analytics a Buy, Sell or Hold?

  • The current Verisk Analytics [VRSK] share price is $285.40. The Score for VRSK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • VRSK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

  • The Verisk Analytics share price today is $285.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

VRSK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.02 Sell
Relative Strength Index (14 RSI): 41.96 Sell
Chaikin Money Flow: -501101 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (288.11 - 297.41) Sell
Bollinger Bands (100): (276.09 - 293.25) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

VRSK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 288.25 Sell
20-day SMA: 292.4 Sell
50-day SMA: 288.1 Sell
200-day SMA: 276.97 Buy
8-day EMA: 288.22 Sell
20-day EMA: 290.37 Sell
50-day EMA: 288.71 Sell
200-day EMA: 274.99 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Verisk Analytics Earnings Growth & VRSK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Verisk Analytics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):